Abstract
Esterification was used to simultaneously increase solubility and permeability of ciprofloxacin, a biopharmaceutics classification system (BCS) class 4 drug (low solubility/low permeability) with solid-state limited solubility. Molecular flexibility was increased to disturb the crystal lattice, lower the melting point, and thereby improve the solubility, whereas lipophilicity was increased to enhance the intestinal permeability. These structural changes resulted in BCS class 1 analogues (high solubility/high permeability) emphasizing that simple medicinal chemistry may improve both these properties.
Original language | English |
---|---|
Pages (from-to) | 2690-2694 |
Number of pages | 5 |
Journal | Journal of Medicinal Chemistry |
Volume | 56 |
Issue number | 6 |
DOIs | |
Publication status | Published - 28 Mar 2013 |
Externally published | Yes |